 |
|
Cardiac arrest due to coronary vasospasm after sugammadex administration -a case report-
Ki Yung Boo, Sang Hyun Park, Sun Kyung Park, Changrock Na, Hyun Jung Kim
Korean J Anesthesiol. 2023;76(1):72-76. Published online 2022 Aug 18 DOI: https://doi.org/10.4097/kja.22335
|
|
Citations to this article as recorded by
 A pharmacovigilance study of FDA adverse events for sugammadex
Xiaoyan Mao, Rong Zhang, Xia Liang, Fan Liu, Yuan Dai, Meng Wang, Haoquan Huang, Ganglan Fu
Journal of Clinical Anesthesia.2024; 97: 111509. CrossRef The effects of sugammadex on isolated human internal mammary artery and saphenous vein rings
Mert C. Ongun, Bahar Oc, Mehmet Oc, Hulagu Bariskaner
Korean Journal of Anesthesiology.2024; 77(4): 484. CrossRef A real-world pharmacovigilance study of cardiac adverse events induced by sugammadex in the FDA adverse event reporting system
Xiao-Na Lin, You-Jie Zeng, Si Cao, Xi-Bo Jing
Expert Opinion on Drug Safety.2024; : 1. CrossRef Epinephrine/sugammadex
Reactions Weekly.2023; 1962(1): 181. CrossRef
|